Quanterix is a life sciences company specializing in biomarker detection with femtomolar sensitivity through its Simoa® (Single Molecule Array) technology. This platform enables precise quantification of protein biomarkers, supporting research in areas such as neurology, oncology, cardiology, inflammation, and infectious diseases.

Quanterix aims to collaborate with researchers and institutions to advance the development and application of biomarker assays. They offer both instrument placement and service-based options, including assay development and sample measurement performed in-house. With these flexible models, they aim to facilitate early disease detection in the biomarker research across Europe.